Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport

ResearchWorks/Manakin Repository

Search ResearchWorks


Advanced Search

Browse

My Account

Statistics

Related Information

Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport

Show full item record

Title: Enhanced effect of microdystrophin gene transfection by HSV-VP22 mediated intercellular protein transport
Author: Xiong, Fu; Xiao, Shaobo; Yu, Meijuan; Li, Wanyi; Zheng, Hui; Shang, Yanchang; Peng, Funing; Zhao, Cuiping; Zhou, Wenliang; Chen, Huanchun; Fang, Liurong; Chamberlain, Jeffrey S.; Zhang, Cheng
Abstract: Background: Duchenne musclar dystrophy (DMD) is an X-linked recessive disease caused by mutations of dystrophin gene, there is no effective treatment for this disorder at present. Plasmidmediated gene therapy is a promising therapeutical approach for the treatment of DMD. One of the major issues with plasmid-mediated gene therapy for DMD is poor transfection efficiency and distribution. The herpes simplex virus protein VP22 has the capacity to spread from a primary transduced cell to surrounding cells and improve the outcome of gene transfer. To improve the efficiency of plasmid-mediated gene therapy and investigate the utility of the intercellular trafficking properties of VP22-linked protein for the treatment for DMD, expression vectors for C-terminal versions of VP22-microdystrophin fusion protein was constructed and the VP22-mediated shuttle effect was evaluated both in vitro and in vivo. Results: Our results clearly demonstrate that the VP22-microdystrophin fusion protein could transport into C2C12 cells from 3T3 cells, moreover, the VP22-microdystrophin fusion protein enhanced greatly the amount of microdystrophin that accumulated following microdystrophin gene transfer in both transfected 3T3 cells and in the muscles of dystrophin-deficient (mdx) mice. Conclusion: These results highlight the efficiency of the VP22-mediated intercellular protein delivery for potential therapy of DMD and suggested that protein transduction may be a potential and versatile tool to enhance the effects of gene delivery for somatic gene therapy of DMD.
URI: http://www.biomedcentral.com/1471-2202/8/50
http://hdl.handle.net/1773/15717

Files in this item

Files Size Format View
1471-2202-8-50.pdf 1.033Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record